Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice


Impaired mitochondrial oxidative phosphorylation (OXPHOS) has been proposed as an etiological mechanism underlying insulin resistance. However, the initiating organ of OXPHOS dysfunction during the development of systemic insulin resistance has yet to be identified. To determine whether adipose OXPHOS deficiency plays an etiological role in systemic insulin resistance, the metabolic phenotype of mice with OXPHOS–deficient adipose tissue was examined. Crif1 is a protein required for the intramitochondrial production of mtDNA–encoded OXPHOS subunits; therefore, Crif1 haploinsufficient deficiency in mice results in a mild, but specific, failure of OXPHOS capacity in vivo. Although adipose-specific Crif1-haploinsufficient mice showed normal growth and development, they became insulin-resistant. Crif1-silenced adipocytes showed higher expression of chemokines, the expression of which is dependent upon stress kinases and antioxidant. Accordingly, examination of adipose tissue from Crif1-haploinsufficient mice revealed increased secretion of MCP1 and TNFα, as well as marked infiltration by macrophages. These findings indicate that the OXPHOS status of adipose tissue determines its metabolic and inflammatory responses, and may cause systemic inflammation and insulin resistance.


Vyšlo v časopise: Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice. PLoS Genet 9(3): e32767. doi:10.1371/journal.pgen.1003356
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pgen.1003356

Souhrn

Impaired mitochondrial oxidative phosphorylation (OXPHOS) has been proposed as an etiological mechanism underlying insulin resistance. However, the initiating organ of OXPHOS dysfunction during the development of systemic insulin resistance has yet to be identified. To determine whether adipose OXPHOS deficiency plays an etiological role in systemic insulin resistance, the metabolic phenotype of mice with OXPHOS–deficient adipose tissue was examined. Crif1 is a protein required for the intramitochondrial production of mtDNA–encoded OXPHOS subunits; therefore, Crif1 haploinsufficient deficiency in mice results in a mild, but specific, failure of OXPHOS capacity in vivo. Although adipose-specific Crif1-haploinsufficient mice showed normal growth and development, they became insulin-resistant. Crif1-silenced adipocytes showed higher expression of chemokines, the expression of which is dependent upon stress kinases and antioxidant. Accordingly, examination of adipose tissue from Crif1-haploinsufficient mice revealed increased secretion of MCP1 and TNFα, as well as marked infiltration by macrophages. These findings indicate that the OXPHOS status of adipose tissue determines its metabolic and inflammatory responses, and may cause systemic inflammation and insulin resistance.


Zdroje

1. RosenED, SpiegelmanBM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (7121)

847–53.

2. FlierJS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 (2)

337–50.

3. KahnBB, FlierJS (2000) Obesity and insulin resistance. J Clin Invest 106 (4)

473–81.

4. HotamisligilGS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (6)

900–17.

5. KusminskiCM, SchererPE (2012) Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab 23 (9)

435–43.

6. PattiME, CorveraS (2010) The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31 (3)

364–95.

7. TormosKV, et al. (2011) Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14 (4)

537–44.

8. ShiX, et al. (2008) Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells. J Biol Chem 283 (45)

30658–67.

9. KohEH, et al. (2007) Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56 (12)

2973–81.

10. Wilson-FritchL, et al. (2004) Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114 (9)

1281–9.

11. RongJX, et al. (2007) Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56 (7)

1751–60.

12. KaamanM, et al. (2007) Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 50 (12)

2526–33.

13. DahlmanI, et al. (2006) Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55 (6)

1792–9.

14. Wilson-FritchL, et al. (2003) Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23 (3)

1085–94.

15. BogackaI, et al. (2005) Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 (5)

1392–9.

16. TedescoL, et al. (2008) Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57 (8)

2028–36.

17. KimSJ, et al. (2012) CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane. Cell Metab 16 (2)

274–83.

18. KwonMC, et al. (2008) Crif1 is a novel transcriptional coactivator of STAT3. EMBO J 27 (4)

642–53.

19. UrsS, et al. (2006) Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res 15 (5)

647–53.

20. XueB, et al. (2007) Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J Lipid Res 48 (1)

41–51.

21. PospisilikJA, et al. (2007) Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131 (3)

476–91.

22. RochaVZ, Libby (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6 (6)

399–409.

23. SunK, KusminskiCM, SchererPE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121 (6)

2094–101.

24. GaoYJ, et al. (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29 (13)

4096–108.

25. ShenQ, ZhangR, BhatNR (2006) MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells. Brain Research 1086: 9–16.

26. ShoelsonSE, LeeJ, GoldfineAB (2006) Inflammation and insulin resistance. J Clin Invest 116 (7)

1793–801.

27. ChenCL, et al. (2008) Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111 (8)

4365–74.

28. OlefskyJM, GlassCK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219–46.

29. SamuelVT, ShulmanGI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148 (5)

852–71.

30. KandaH, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (6)

1494–505.

31. LumengCN, MaillardI, SaltielAR (2009) T-ing up inflammation in fat. Nat Med 15 (8)

846–7.

32. NishimuraS, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15 (8)

914–20.

33. HotamisligilGS, et al. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (5)

2409–15.

34. SchenkS, SaberiM, OlefskyJM (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118 (9)

2992–3002.

35. MakowskiL, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7 (6)

699–705.

36. GareusR, et al. (2008) Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 8 (5)

372–83.

37. EguchiJ, et al. (2011) Transcriptional control of adipose lipid handling by IRF4. Cell Metab 13 (3)

249–59.

38. van RooijenN, HendrikxE (2010) Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 605: 189–203.

39. LowellBB, ShulmanGI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307 (5708)

384–7.

40. MorinoK, PetersenKF, ShulmanGI (2006) Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 Suppl 2: S9–S15.

41. SchmidAI, et al. (2011) Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34 (2)

448–53.

42. FreyerC, LarssonNG (2007) Is energy deficiency good in moderation?. Cell 131 (3)

448–50.

43. WredenbergA, et al. (2006) Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun 350 (1)

202–7.

44. CrunkhornS, et al. (2007) Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem 282 (21)

15439–50.

45. SutherlandLN, et al. (2008) Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am J Physiol Endocrinol Metab 295 (5)

E1076–83.

46. NewtonBW, et al. (2011) Proteomic analysis of 3T3-L1 adipocyte mitochondria during differentiation and enlargement. J Proteome Res 10 (10)

4692–702.

47. LuRH, et al. (2010) Mitochondrial development and the influence of its dysfunction during rat adipocyte differentiation. Mol Biol Rep 37 (5)

2173–82.

48. HerreroL, et al. (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 107 (1)

240–5.

49. PetersenKF, et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350 (7)

664–71.

50. OsbornO, OlefskyJM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18 (3)

363–74.

51. XuH, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (12)

1821–30.

52. WeisbergSP, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (12)

1796–808.

53. LumengCN, BodzinJL, SaltielAR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117 (1)

175–84.

54. LeeKW, et al. (2011) Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor gamma Activity and on Glucose Uptake by Thiazolidinediones. Diabetes Metab J 35 (4)

340–7.

55. EstesBT, et al. (2010) Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5 (7)

1294–311.

56. BoldoghIR, PonLA (2007) Purification and subfractionation of mitochondria from the yeast Saccharomyces cerevisiae. Methods Cell Biol 80: 45–64.

57. ParkSY, et al. (2005) Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver. Diabetes 54 (9)

2514–24.

58. KangSM, et al. (2008) CD4+CD25+ regulatory T cells selectively diminish systemic autoreactivity in arthritic K/BxN mice. Mol Cells 25 (1)

64–9.

59. KasumovT, et al. (2010) Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 401 (1)

154–61.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2013 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa